Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease

Am J Gastroenterol. 2002 Oct;97(10):2688-90. doi: 10.1111/j.1572-0241.2002.06064.x.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Arthralgia / complications
  • Arthralgia / diagnosis*
  • Arthritis / complications
  • Arthritis / diagnosis*
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Humans
  • Infliximab
  • Prospective Studies
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Infliximab